Skip to main content

Table 2 Fluid balance of patients included in the study according to treatment group

From: The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study

Fluid balance

All patients

(n = 124)

NacA group

(n = 60)

Control group

(n = 64)

P value

Before (2 days) contrast infusion

1145.6 (178.2)

1000.9 (266.3)

1269.0 (244.2)

0.46

Before (1 day) contrast infusion

1399.7 (151.0)

1117.5 (198.4)

1655.9 (225.3)

0.08

Day of contrast infusion

1463.6 (159.4)

1133 (194.8)

1633.4 (227.6)

0.09

First day after contrast infusion

1310.4 (167.1)

1317.1 (256.4)

1306.3 (224.3)

0.97

Second day after contrast infusion

996.1 (137.6)

1095.6 (237.8)

945.3 (163.0)

0.59

Third day after contrast infusion

844.9 (174.2)

902.9 (298.2)

774.4 (195.8)

0.71

Fourth day after contrast infusion

869.8 (167.4)

1042.5 (241.2)

691.9 (236.8)

0.30

Fifth day after contrast infusion

897.6 (235.5)

870.3 (340.3)

967.4 (234.3)

0.70

  1. Data presented as mean (SE)
  2. NacA group Treatment (N-acetylcysteine and ascorbic acid) group